The following data is part of a premarket notification filed by Baxter Healthcare Corp. with the FDA for Cytomegalovirus Fluorescent Monoclonal Antibody.
| Device ID | K894002 |
| 510k Number | K894002 |
| Device Name: | CYTOMEGALOVIRUS FLUORESCENT MONOCLONAL ANTIBODY |
| Classification | Antisera, Conjugated Fluorescent, Cytomegalovirus |
| Applicant | BAXTER HEALTHCARE CORP. P.O. BOX 3093 Bellevue, WA 98009 |
| Contact | Lorraine Weaver |
| Correspondent | Lorraine Weaver BAXTER HEALTHCARE CORP. P.O. BOX 3093 Bellevue, WA 98009 |
| Product Code | LIN |
| CFR Regulation Number | 866.3175 [🔎] |
| Decision | Substantially Equivalent (SESE) |
| Type | Traditional |
| 3rd Party Reviewed | No |
| Combination Product | No |
| Date Received | 1989-06-05 |
| Decision Date | 1989-08-10 |
| Device Identifier | submissionNumber | Supplement |
|---|---|---|
| 05391516745888 | K894002 | 000 |
| 05391516745871 | K894002 | 000 |
| 05391516745161 | K894002 | 000 |